Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Indo US BioTech IPO.
July 1, 2024 2:30:00 PM
Biopharma deal activity plummeted down to Earth in the second quarter, with just a handful of M&A transactions and IPOs studding the mostly dark skies. | The slow quarter follows an exciting first one ...
Published by : FierceBiotechJuly 1, 2024 11:19:00 AM
Artiva Biotherapeutics has become the latest biotech to set out IPO ambitions for the summer, as the allogeneic natural killer (NK) cell therapy company pushes its lead program through automimmune ...
Published by : FierceBiotechJune 28, 2024 1:45:00 PM
Alumis, an immunology drug developer on the cusp of Phase 3, will go public Friday in a smaller IPO than it originally projected. The Bay Area startup sold 13.12 million shares $ALMS at $16 apiece to ...
Published by : ENDPOINTS NEWSJuly 2, 2024 1:07:00 AM
(Reuters) - Germany-based Northern Data AG is exploring a U.S. initial public offering for its artificial intelligence cloud computing and data center units at a valuation of as much as $16 billion, ...
Published by : U.S. News & World ReportJuly 1, 2024 6:34:00 PM
Like many of its cell therapy peers, Artiva, which originally sought an IPO in 2021, has shifted its strategy to ride a wave of investor interest in autoimmune disease research.
Published by : BioPharma DiveJune 24, 2024 5:45:00 PM
Biotech IPOs have shown signs of a rebound this year, but a string of poor post-debut performances have tempered expectations of a full market recovery. Alumis, previously known as Esker Therapeutics, ...
Published by : ReutersJune 26, 2024 2:18:00 AM
Suzhou, China-headquartered Ascentage Pharma Group Corp. Ltd. has filed plans for a confidential IPO to the U.S. SEC for a potential dual listing on both the U.S. and Hong Kong stock exchanges. News ...
Published by : BioWorldJuly 2, 2024 8:30:00 PM
Bio: " I am Michael, and soon will be a graduate of Bachelor of Commerce at the University of Toronto, a specialist in finance and economics with high distinction. I aspire to become a CFA charter and ...
Published by : Seeking AlphaJune 19, 2024 12:04:00 AM
The US government deficit is set to reach almost $2tn this year, the Congressional Budget Office warned, saying new commitments to fund Ukraine and Israel would push up spending t ...
Published by : The Financial TimesJune 24, 2024 8:32:46 PM
The NHS has turned to US drugs giant Pfizer over its British rival GSK for vaccines against Respiratory Syncytial Virus (RSV), the winter infection known as the �silent killer� of the ...
Published by : The Telegraph on MSNApril 15, 2024 2:30:15 AM
But we cannot be just a single focus market, we do have to diversify,' says Cha, who steps down from her role on April 24 She is confident Hong Kong's turbulent political situation of the last few ...
Published by : South China Morning Post on MSNThe IPO Shares of Indo US Bio-Tech Limited IPO are proposed to list on Friday, May 11, 2018 at BSE SME. The public issue of Indo US BioTech IPO was opened on Apr 30, 2018 and closed for subscription on May 3, 2018. Indo US BioTech IPO Listing Date and Information:
The allotment status of Indo US Bio-Tech Limited IPO is now available online. The public issue of Indo US BioTech IPO was open on Apr 30, 2018 and closed for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME.
The issue of Indo US Bio-Tech Limited opens on Apr 30, 2018 and closes for subscription on May 3, 2018. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 51 Per Equity Share.
Indo US Bio-Tech Limited is entering in the capital market with an IPO of 1,430,000 Equity Shares of Rs 10 aggregating up to Rs 72.93 Crore. The price for the issue has been set at Rs 51 Per Equity Share.
Incorporated in 2004, Gujarat based Indo US Bio-Tech Limited is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing ). The company has its own laboratory for seed testing at Junagadh.
The issue opens on Apr 30, 2018 and closes for subscription on May 4, 2018. The equity shares of the company to be list at BSE SME.
The Indo US BioTech IPO is proposed to open on April 30, 2018. The IPO application ends on May 3, 2018.
Retail investors can apply in the retail or non-institutional investor category from April 30, 2018 to May 3, 2018. The Indo US BioTech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Indo US BioTech IPO will open for subscription on April 30, 2018. The public issue will close on May 3, 2018.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
